Compare Novo Nordisk A/S (NVO) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Opendoor Technologies Inc — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Opendoor Technologies Inc trades at $4.48 (market cap $4.29B). The key difference: Novo Nordisk A/S is far larger — about 51.4× Opendoor Technologies Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| NVO | OPEN | |
|---|---|---|
Market Cap | $220.53B | $4.29B |
Sector | Health | Real Estate |
52-Week High | $71.70 | $10.52 |
52-Week Low | $35.29 | $1.84 |
Enterprise Value | $239.49B | $4.63B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
